MeSH D058447 - eye pain
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Alembic Pharmaceuticals | Bromfenac | Bromfenac | 2019-06-21 | |||
| Amneal Pharmaceuticals | Bromfenac | Bromfenac | 2024-07-29 | |||
| Amring Pharmaceuticals | Bromfenac | Bromfenac | 2013-01-09 | |||
| Apotex | Bromfenac | Bromfenac | 2014-06-19 | |||
| Bausch Health Companies | Bromfenac | Bromday | 2005-03-24 | |||
| Bromfenac | Prolensa | 2024-01-16 | 2013-04-05 | |||
| Bromfenac | Yellox | 2011-05-18 | ||||
| Chartwell Pharmaceuticals | Bromfenac | Bromfenac | 2015-02-10 | |||
| Eugia Pharma Specialties | Bromfenac | Bromfenac | 2022-03-18 | |||
| Gland Pharma | Bromfenac | Bromfenac | 2020-03-17 | |||
| Lupin Research | Bromfenac | Bromfenac | 2023-08-15 |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/1
Phase 2
0%0/0
Phase 3
100%2/2
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use